Nalidixic Acid

萘啶酸

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameNalidixic Acid
Drug Alias Nameacide nalidixique萘利啶酸acidum nalidixicum萘啶酮酸Uriben +[8] 
ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > Quinolone antibiotics
Mechanisms of ActionTopoisomerase IV inhibitorsBacterial DNA gyrase inhibitorsDNA topoisomerase inhibitors
TargetsTopoisomerase IVBacterial DNA gyraseDNA topoisomerase
Therapy Area/IndicationsUrinary Tract Infections
Global Approved IndicationsUrinary Tract Infections
Approved Indications in ChinaUrinary Tract Infections
Original Approved Country/TerritoryUnited States
Original Approved Date1964/03/06
Country/TerritoryUnited StatesMainland China
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesSanofi
China Registration ClassN/A

Develop Information

Active CompaniesShandong Boshan Pharmaceutical Co Ltd
Inactive CompaniesSanofi-Aventis U.S. Llc
Active IndicationsUrinary Tract Infections
Inactive IndicationsN/A

Other Information

ATC CodeJ01MB02
Related LinksWikipediaDrugBankKEGG